Issue 3 2026
Volume 3

Issue 3 2026

Issue 3
GI Oncology Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Richard Kim • Wei Shi • Xiuzhi Wu • Xianzhang Meng • Kristin Ryan • Stephen Chan • Arndt Vogel
doi.org/10.69690/ODMJ-001-1026-8138